Please login to the form below
Webinar: Understanding Patient Willingness to Pay
What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?
A key feature of emerging markets is that patients often have to self-fund a high proportion of their healthcare costs. While private health insurance coverage is increasing in many emerging markets, penetration typically remains low, even among middle to high income segments of the population.
http://www.researchpartnership.com/news/2016/09/webinar-understanding-patient-willingness-to-pay/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Healthcare in the age of AI: How will artificial intelligence impact future decision-making?
- Authored by: Constanza Salas, Jhon Galindo and Rachel Howard
Research Partnership
- Therapy Watch launches new tracker covering Postpartum Depression
- The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry
Research Partnership
- Value-based pricing reform: Strengthening the ‘front door’ to the Colombian pharmaceutical market
- Authored by: Marc Garcia and Tania Rodrigues
Research Partnership
- Infographic: Rare Diseases in China
- How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.
Research Partnership
- New syndicated COPD report now available
- Living with COPD 2023
Research Partnership
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics.
Research Partnership
